Delivery Order SPE2DB20D1047-SPE2DB25FF67E
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,563.97 to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets (30-count units) on July 23, 2025, with an ultimate completion date of July 24, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract number SPE2DX), which carries a potential...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,545.17 to AmerisourceBergen Drug Corp for Modafinil 100 mg tablets (30-count supply) on September 25, 2025, with a completion date of September 26, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designations and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,079.60 to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets (30-count units) on November 10, 2025, with an ultimate completion date of November 12, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets in quantities of 30 units under a firm fixed-price contract valued at $7,296.70. The award, issued on August 15, 2025, with an ultimate completion date of August 18, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as the...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30 units. This is a firm fixed-price delivery order with a ceiling value of $1,794.95 and an ultimate completion date of October 27, 2025. The contract was not set-aside and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30 units, with a ceiling value of $1,125.60. This is a firm fixed-price delivery order with an ultimate completion date of September 11, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates...
- The Defense Logistics Agency awarded a delivery order valued at $5,370.31 to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets in quantities of 30 on June 3, 2025, with an ultimate completion date of June 4, 2025. This firm fixed-price delivery order represents a non-competitive set-aside and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,013.80 to AmerisourceBergen Drug Corp for the supply of Modafinil 100 mg tablets (30-count packages) on November 4, 2025, with an ultimate completion date of November 5, 2025. This firm fixed-price, non-competitive delivery order was executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026....
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30, with a ceiling value of $28,380.00. This is a firm fixed-price delivery order with an ultimate completion date of June 20, 2025, and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Modafinil 100 mg tablets in 30-count packages, with a ceiling value of $4,827.61 and firm fixed pricing. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of August 21, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor and critical...
- SPE2DB20D1047Indefinite Delivery Contract
- SPE2DB20D1047-SPE2DB25FF67EDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,474.63 to AmerisourceBergen Drug Corp on June 16, 2025, for the supply of Modafinil 100 mg tablets in quantities of 30 units. This is a firm fixed price delivery order with an ultimate completion date of June 17, 2025, and represents a non-competitive set-aside delivery against a larger contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs, particularly supporting military and veteran healthcare systems across the Defense Health Agency and related organizations. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply an extensive range of pharmaceutical products, brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs worldwide. AmerisourceBergen Drug Corp's significant federal contract portfolio demonstrates its capability to fulfill diverse medical supply requirements through open competition and established prime vendor relationships.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 6/16/25 |